NCT05183399|CompletedFDA Device
Loading search results
Sponsor study identifier
observational
30
0 countries
N/A
Study Start
December 1, 2016
Actual (reported)Primary Completion
May 19, 2017
Actual (reported)Study Completion
February 14, 2021
Actual (reported)The purpose of this study is to confirm device efficacy and safety of the GORE® VIABAHN® Endoprosthesis (hereafter "VB device") for the treatment of traumatic or iatrogenic vessel injury in thoracic, abdominal, and pelvic arteries (except the aorta, coronary, brachiocephalic, carotid, vertebral and pulmonary arteries).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 14, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 1, 2016
Actual (reported)May 19, 2017
Actual (reported)February 14, 2021
Actual (reported)December 20, 2021
Actual (reported)January 10, 2022
Actual (reported)Technical Success
A technical success is defined as is a successful device implantation and a successful hemostasis.
Day 1 to 1 Month
Safety
Day 1 to 12 months
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with traumatic or iatrogenic vessel injuries in thoracic, abdominal, and pelvic arteries (except the aorta, coronary, brachiocephalic, carotid, vertebral and pulmonary arteries ) with a reference vessel diameter ranging from 4.0 to 12.0mm.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
30 participants (actual enrollment reported by the registry).
First Submitted
December 20, 2021
First Posted
January 10, 2022
Study Start
December 1, 2016
Actual (reported)GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study
Primary Completion
May 19, 2017
Actual (reported)Study Completion
February 14, 2021
Actual (reported)Last Updated
January 10, 2023
Record last verified: 2023-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: